Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 22 of 23, showing 5 Applications out of 112 total, starting on record 106, ending on 110

# Protocol No Study Title Investigator(s) & Site(s)

106.

ECCT/21/05/02   BFTAF Elderly Switch Study
    Switching virally suppressed HIV-1 infected elderly adults (age ≥ 60 years) without prior confirmed virological failure from current anti-retroviral regimen to bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF)   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
View

107.

ECCT/14/05/03   Invivo II study
    Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   
Principal Investigator(s)
1. Ben Andagalu
Site(s) in Kenya
Kombewa Clinical Research Center
 
View

108.

ECCT/24/09/03   WHO PPT vs DPEP FOR STI IN MSM
    WHO-Recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya.   
Principal Investigator(s)
1. Susan Graham
2. Fredrick Otieno
3. Joshua Kimani
Site(s) in Kenya
1. Pwani Research Centre, in collaboration with two local community-based organisations (the HIV and AIDS People Alliance of Kenya [HAPA Kenya] and the International Centre for Reproductive Health [ICRH]) (Mombasa county)
2. Anza Mapema Clinic (Kisumu county)
3. Sex Workers Outreach Programme Clinic (Nairobi City county)
 
View

109.

ECCT/14/12/01   Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE)
    XALIA LEA- Xarelto® for Long-term and  Initial Anticoagulation in Venous  Thromboembolism (VTE) in Latin America,  EMEA and Asia   
Principal Investigator(s)
1. Anne Njeri Mugera Njambi Mugera
2. Dr. Martin N Wanyoike Njoroge Wanyoike
3. Charles Muthui Kariuki Muthui Kariuki
4. FEROZ ALI Allibhoy
Site(s) in Kenya
1. Primecare Heart Clinic (Nairobi City county)
2. Dr. Silversteins Clinic (Nairobi City county)
3. Nairobi Cardiovascular Clinic (Nairobi City county)
4. Agah Khan Kisumu (Kisumu county)
 
View

110.

ECCT/13/04/02  
    XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study   
Principal Investigator(s)
1. Dr Charles Muthui Kariuki
Site(s) in Kenya
Nairobi Cardiovascular Clinic
 
View